Skip to main content
. 2020 Jan 6;20:12. doi: 10.1186/s12885-019-6425-3

Table 1.

Correlation of ARID1a, BRG1 and BRM expression for the entire patients cohort

ARID1a expression BRG1 expression BRM expression
Negative Positive p-value Negative Positive p-value Negative Positive p-value
Total 560* 58 10.4% 502 89.6% 563* 19 3.4% 544 96.6% 578* 57 9.9% 521 90.1%
Sex
 Female 65 7 10.8% 58 89.2% 0.831 67 1 1.5% 66 98.5% 0.715 68 11 16.2% 57 83.8% 0.080
 Male 495 51 10.3% 444 89.7% 496 18 3.6% 478 96.4% 510 46 9.0% 464 91.0%
Age group
 <65 185 17 9.2% 168 90.8% 0.399 186 4 2.2% 182 97.8% 0.239 191 20 10.5% 171 89.5% 0.199
 >65 174 19 10.9% 155 89.1% 170 9 5.3% 161 94.7% 173 20 11.6% 153 88.4%
pT stage
 1 81 9 11.1% 72 88.9% 0.657 79 3 3.8% 76 96.2% 0.448 86 8 9.3% 78 90.7% 0.981
 2 72 8 11.1% 64 88.9% 73 1 1.4% 72 98.6% 72 6 8.3% 66 91.7%
 3 385 41 10.6% 344 89.4% 388 13 3.4% 375 96.6% 398 41 10.3% 357 89.7%
 4 19 0 0% 19 100% 20 2 10% 18 90.0% 20 2 10.0% 18 90.0%
Lymph node metastasis
 pN0 217 31 14.3% 186 85.7% 0.086 216 8 3.7% 208 96.3% 0.952 227 20 8.8% 207 91.2% 0.651
 pN 1 196 13 6.6% 183 93.4% 197 6 3% 191 97.0% 194 23 11.9% 171 88.1%
 pN 2 74 7 9.5% 67 90.5% 74 2 2.7% 72 97.3% 79 6 7.6% 73 92.4%
 pN 3 71 7 9.9% 64 90.1% 74 3 4.1% 71 95.9% 76 8 10.5% 68 89.5%
Grading
 G1 4 1 25% 3 75% 0.186 5 0 0% 5 100% < 0.001 6 0 0% 6 100% 0.119
 G2 218 16 7.3% 202 92.7% 217 3 1.4% 214 98.6% 221 20 9.0% 201 91.0%
 G3 167 22 13.2% 145 86,8% 172 10 5.8% 162 94.2% 177 24 13.6% 153 86.4%

*Total numbers of patients do not add due to missing clinical data in some cases